Enzon Pharmaceuticals, Inc. (BST:EZ1)

Market Cap	2.86M
Revenue (ttm)	n/a
Net Income (ttm)	-2.22M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	765
Open	0.0350
Previous Close	0.0365
Day's Range	0.0350 - 0.0350
52-Week Range	0.0350 - 0.2300
Beta	n/a
RSI	22.02
Earnings Date	Nov 14, 2025

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 1
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: EZ1

Financial Performance

Financial numbers in USD